Bank of New York Mellon Corp Sells 47,707 Shares of Encompass Health Co. (NYSE:EHC)

Bank of New York Mellon Corp decreased its stake in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 3.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,315,320 shares of the company's stock after selling 47,707 shares during the period. Bank of New York Mellon Corp owned 1.31% of Encompass Health worth $121,470,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. International Assets Investment Management LLC acquired a new position in shares of Encompass Health during the third quarter worth approximately $4,241,000. Wealth Enhancement Advisory Services LLC lifted its holdings in Encompass Health by 1.5% during the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 13,151 shares of the company's stock worth $1,271,000 after buying an additional 199 shares in the last quarter. State of Alaska Department of Revenue boosted its position in Encompass Health by 6.5% in the 3rd quarter. State of Alaska Department of Revenue now owns 12,866 shares of the company's stock valued at $1,242,000 after buying an additional 790 shares during the last quarter. First Trust Direct Indexing L.P. increased its stake in shares of Encompass Health by 11.9% in the 3rd quarter. First Trust Direct Indexing L.P. now owns 2,851 shares of the company's stock valued at $276,000 after buying an additional 304 shares during the period. Finally, US Bancorp DE raised its position in shares of Encompass Health by 18.7% during the third quarter. US Bancorp DE now owns 1,259 shares of the company's stock worth $122,000 after acquiring an additional 198 shares during the last quarter. Institutional investors own 97.25% of the company's stock.

Remove Ads

Analyst Ratings Changes

EHC has been the topic of several recent research reports. William Blair reiterated an "outperform" rating on shares of Encompass Health in a report on Friday, February 7th. Royal Bank of Canada reaffirmed an "outperform" rating and set a $110.00 price objective on shares of Encompass Health in a research note on Tuesday, February 11th. StockNews.com upgraded Encompass Health from a "hold" rating to a "buy" rating in a report on Saturday, February 15th. Barclays increased their price target on shares of Encompass Health from $116.00 to $118.00 and gave the company an "overweight" rating in a research report on Friday, February 7th. Finally, KeyCorp upped their target price on shares of Encompass Health from $117.00 to $120.00 and gave the company an "overweight" rating in a research note on Monday, February 10th. Ten equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, Encompass Health presently has an average rating of "Buy" and a consensus target price of $107.67.

Encompass Health Stock Up 1.7 %

Shares of EHC stock traded up $1.67 during trading hours on Wednesday, hitting $100.12. 770,900 shares of the company were exchanged, compared to its average volume of 628,668. The company has a market capitalization of $10.08 billion, a PE ratio of 22.45, a PEG ratio of 2.31 and a beta of 0.92. Encompass Health Co. has a 52 week low of $74.27 and a 52 week high of $104.55. The business has a 50 day moving average of $96.74 and a two-hundred day moving average of $96.59. The company has a current ratio of 1.05, a quick ratio of 1.04 and a debt-to-equity ratio of 0.84.

Encompass Health (NYSE:EHC - Get Free Report) last released its quarterly earnings results on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. Analysts anticipate that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, April 17th. Shareholders of record on Tuesday, April 1st will be paid a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 0.68%. The ex-dividend date is Tuesday, April 1st. Encompass Health's payout ratio is 15.25%.

Insider Transactions at Encompass Health

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of the business's stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $98.29, for a total transaction of $495,578.18. Following the sale, the chief accounting officer now directly owns 69,164 shares of the company's stock, valued at $6,798,129.56. The trade was a 6.79 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Company insiders own 2.10% of the company's stock.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.